using a weakly immunogenic syngeneic murine lung cancer tumor system ( line 1 , balb/cbyj mice ) , we have administered recombinant human il-1 alpha , recombinant human il-1 beta , and the peptide fragment 163-171 of il-1 beta in combination with a vaccine of radiated tumor cells .
C0086418
human
C0021753
il-1